Parkinson's Lunch & Learn: What's New With PD Research

This engaging three-part program offers meaningful conversations with renowned medical experts and movement disorder specialists.

In our third session, Dr. Jeff Bronstein will discuss what is new with PD research regarding the causes of PD and treatments that hopefully will stop the progression.

Don’t miss this opportunity to learn, connect, and share over lunch!

Thank you to our event partners, Abbott, Abbvie, Acadia, Amneal, Medtronic, and Supernus for making this event possible.

Jeff Bronstein received his bachelor's degree from the University of California, Berkeley and M.D. and Ph.D. from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA. Dr. Bronstein also completed a postdoctoral fellowship in molecular biology before being appointed an Assistant Professor of Neurology. He was later appointed Director of the Movement Disorders Program at UCLA and Professor of Neurology and Molecular Toxicology.

His interests and expertise include the management of Parkinson's disease (PD) and other movement disorders, surgical treatment of PD, and developing new therapies for patients.

His laboratory studies the cause of PD using cell models and a newly developed zebrafish model. His work supported by the NIH and private foundations.

Dr. Bronstein also directs clinical trials in order to develop new therapies for PD that include transplantation and deep brain stimulation. He has received several awards and is widely published in the field.

Host or Publisher Parkinson's Community Los Angeles